利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

9 条记录 (耗时 0.022 秒)

    2-Pyridinylcyclopropylbenzamide fungicides
    2.
    发明公开
    2-Pyridinylcyclopropylbenzamide fungicides 审中-公开
    2-吡啶基环丙基苯甲酰胺类杀真菌剂

    公开(公告)号：EP2289880A1

    公开(公告)日：2011-03-02

    申请号：EP09356045.6

    申请日：2009-07-08

    申请人： Bayer CropScience AG

    发明人： Coqueron, Pierre-Yves

    IPC分类号： C07D213/00 ,  C07D213/36 ,  A01N43/40

    CPC分类号： C07D213/00 ,  C07D213/36

    摘要： The present invention relates to novel N-[2-(2-pyridinyl)cyclopropyl]benzamide derivatives (I), their process of preparation, their use as fungicides, particularly in the form of fungicidal compositions, and methods for the control of phytopathogenic fungi of plants using these compounds or their compositions.

    摘要翻译： 本发明涉及新的N- [2-（2-吡啶基）环丙基]苯甲酰胺衍生物（I），它们的制备方法，它们作为杀真菌剂的用途，特别是杀真菌组合物的形式，以及防治植物病原性真菌 使用这些化合物或其组合物的植物。

    PROCESS FOR THE SYNTHESIS OF SUBSTITUTED UREA COMPOUNDS
    7.
    发明公开
    PROCESS FOR THE SYNTHESIS OF SUBSTITUTED UREA COMPOUNDS 审中-公开
    VERFAHREN ZUR SYNTHESE VON SUBSTITUIERTEN HARNSTOFFVERBINDUNGEN

    公开(公告)号：EP2882712A2

    公开(公告)日：2015-06-17

    申请号：EP13750964.2

    申请日：2013-07-26

    申请人： BIAL - Portela & Cª S.A.

    发明人： RUSSO, Domenico ,  WAHNON, Jorge Bruno Reis ,  MATON, William ,  ESZENYI, Tibor

    IPC分类号： C07D213/00

    CPC分类号： C07D401/04 ,  C07D213/00 ,  C07D213/50 ,  C07D213/53

    摘要： A process for preparing a substituted urea compound of Formula II or Formula I, or a pharmaceutically acceptable salt or ester thereof, Formula II, Formula I the process comprising the reaction of an intermediate of Formula II′ or Formula 1′, Formula II′, Formula I′ with a carbamoyl halide of the formula: R1R2NC(=0)Hal, in a solvent consisting essentially of pyridine, wherein Hal represents Cl, F, I or Br, and wherein ring A, and R1, R2, R5, V, W, X, Y and Z are as defined herein.

    摘要翻译： 制备式II或式I的取代的脲化合物或其药学上可接受的盐或其酯，式II，式I的方法包括式II'或式1'的中间体，式II'， 式I'与具有式R 1 R 2 NC（= O）Hal的氨基甲酰卤在基本上由吡啶组成的溶剂中，其中Hal表示Cl，F，I或Br，其中环A和R1，R2，R5，V ，W，X，Y和Z如本文所定义。

    FUNKTIONELLE TERPYRIDIN-METALLKOMPLEXE, VERFAHREN ZU DEREN HERSTELLUNG UND OLIGONUKLEOTID-KONJUGATE MIT TERPYRIDIN-METALLKOMPLEXEN
    9.
    发明公开
    FUNKTIONELLE TERPYRIDIN-METALLKOMPLEXE, VERFAHREN ZU DEREN HERSTELLUNG UND OLIGONUKLEOTID-KONJUGATE MIT TERPYRIDIN-METALLKOMPLEXEN 失效
    功能三联吡啶金属络合物用于生产和寡核苷酸缀合物金属配合物三联吡啶

    公开(公告)号：EP0778844A1

    公开(公告)日：1997-06-18

    申请号：EP95931224.0

    申请日：1995-08-30

    申请人： Novartis AG

    发明人： HÄNER, Robert ,  HALL, Jonathan ,  HÜSKEN, Dieter ,  PIELES, Uwe ,  MOSER, Heinz

    IPC分类号： C12N15 ,  A61K31 ,  A61P35 ,  C07D213 ,  C07D471 ,  C07F5 ,  C07F9 ,  C07H21 ,  C12Q1

    CPC分类号： C07H21/00 ,  C07D213/00 ,  C12Q1/6816 ,  G01N2458/40

    摘要： Disclosed are compounds of formula (V), wherein R2 and R7, independently of each other, are H, C1-C4 alkyl, C1-C4 alkoxy, C7-C12 aralkyl, C6-C16 aryl or halogen; R3 and R6, independently of each other, are H, C1-C4 alkyl, C7-C12 aralkyl or C6-C16 aryl; R4 is H, C1-C20 alkyl, C5-C8 cycloalkyl, C6-C12 aryl or C7-C12 aralkyl, the alkyl, cycloalkyl, aralkyl and aryl radicals being unsubstituted or substituted with C1-C4 alkoxy, F, Cl, Br, -CN, C1-C4 alkyl or -NO2; Me is a lanthanide metal or yttrium; Y is an anion of an acid; n stands for 2 or 3 and m is 1, 2 or 3; R9 is a radical of formula (VI) -Xp-A-X'q-A'r-Oligo, and R8 is H, C1-C4 alkyl, C1-C4 alkoxy, C7-C12 aralkyl, C6-C16 aryl, or R9 is H, C1-C4 alkyl, C1-C4 alkoxy, C7-C12 aralkyl, C6-C16 aryl and R8 is a radical of formula (VI); p, q and r, independently of one another, are 0 or 1; X and X', independently of each other, are a radical unsubstituted or substituted by C1-C4 alkoxy, F, Cl, Br, -CN, C1-C4 alkyl or -NO2 substituted radical selected from the group consisting of C1-C20 alkylene, C2-C12 alkenylene, C2-C12 alkinylene, -(CxH2xO)y-, wherein x equals a number from 2 to 6 and y equals a number from 1 to 20, C5-C8 cycloalkylene, C6-C12 arylene and C7-C12 aralkylene; A and A', independently of each other, are -O-, -S-, -S-S-, -NR12-CO-NR12-CO-NR12-, -NR12-CS-NR12-, -NR12-, -NR12-C(O)-O-, -C(O)O-, -C(O)S-, -C(O)NR12-, -C(S)S-, -C(S)O-, -C(S)NR12-, -SO2NR12-, -SO2-, -P(O)(OH)O-, P(S)(SH)S-, -P(S)(SH)O-, -P(S)(OH)O-, -P(O)(SH)S-, -P(O)(OH)S-, -P(O)(SH)O-, -P(O)(OH)-NR12-, -P(S)(SH)-NR12-, -P(S)(OH)-NR12-, -P(O)(SH)-NR12-, -HP(O)O-, -HP(S)S-, -HP(O)NR12- or -HP(S)NR12-, R12 being H or C1-C6 alkyl; and oligo is a natural, modified or synthetic sequence of natural, modified or synthetic deoxynucleosides or peptide nucleic acid units which are bonded via a nucleic base, an internucleotide bridge or a sugar and whose inner region is complementary to a target RNA.